Scout | NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

This opportunity is no longer accepting applications.

grant

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

This grant opportunity is for researchers to conduct phase I clinical trials focusing on diagnostic and therapeutic interventions for heart, lung, blood, and sleep disorders in both adults and children. Trials can be carried out at one or multiple sites. Applicants must be prepared to start the clinical trial within the first three months of funding. Before funding is awarded, all necessary re…

Source

Agency: National Institutes of Health

Sub-agency: National Heart, Lung, and Blood Institute

Program: SBIR

Award

Award Ceiling: $1.5M

Funding Amount: $1.5M

Dates

Opportunity Released: April 1, 2024

Open for Submission: April 1, 2024

Submission Deadline: January 7, 2027

Application Window Closes: January 7, 2027

Keywords

clinical trials

investigator-initiated

HLBS disorders

heart disorders

lung disorders

blood disorders

sleep disorders

therapeutic interventions

diagnostic interventions

regulatory approvals

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers